Article

AMO, Alcon in dispute over phaco patents

Santa Ana, CA-Advanced Medical Optics (AMO) is claiming, in a complaint filed in federal court, that Alcon's Infiniti and Series 20000 Legacy phacoemulsification systems infringe AMO patents for advanced fluidics technologies in the removal of cataracts.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Related Content
Q&A: Sofia Androudi on retinal disorders mimicking inherited retinal diseases
September 16th 2025

Q&A: Sofia Androudi on retinal disorders mimicking inherited retinal diseases

3 Things You Should Know About the GA Pipeline
September 16th 2025

NK Insights: An Interactive Corneal Sensitivity Testing Workshop

Status of the inner retinal layers in patients with multiple sclerosis
September 16th 2025

Status of the inner retinal layers in patients with multiple sclerosis

3 Things You Should Know About the GA Pipeline
September 16th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

Ocugen and Kwangdong complete licensing agreement for OCU400 gene therapy in Korea
September 16th 2025

Ocugen and Kwangdong complete licensing agreement for OCU400 gene therapy in Korea

Long-term atropine use linked to higher risk of ocular complications in children
September 16th 2025

Long-term atropine use linked to higher risk of ocular complications in children

© 2025 MJH Life Sciences

All rights reserved.